Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,138,833
+$133,881 QoQ
Shares Held
31,757
-0.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#378
of 966 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Pinnacle Financial Partners, Inc. holds $52,100,328 across 12 Medical Devices names. DXCM ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
249,681 | $22,656,052 | |
| 2 | BSX |
Boston Scientific Corp
|
193,225 | $8,246,841 | |
| 3 | MDT |
Medtronic plc
|
72,108 | $5,641,006 | |
| 4 | SYK |
Stryker Corp
|
17,469 | $5,499,938 | |
| 5 | EW |
Edwards Lifesciences Corp
|
32,118 | $2,905,394 | |
| 6 | DXCM |
Dexcom Inc
This page
|
31,757 | $2,138,833 | |
| 7 | GMED |
Globus Medical Inc
|
17,607 | $1,391,128 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
11,747 | $1,011,299 |
All Filings in DXCM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,138,833 | 31,757 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,004,952 | 31,926 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,878,268 | 28,300 | Shares | Defined | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||